NEU 1.52% $12.94 neuren pharmaceuticals limited

Share Price, page-12309

  1. 1,146 Posts.
    lightbulb Created with Sketch. 566
    Yes I suspect you're right Hottod, it's the scenario that makes the most sense especially after looking through the patents. I did note in my research yesterday the indications you outlined, in that case it should follow that any undisclosed indications will be specified in a new patent application. Hopefully the scope of the patent application is wider than anticipated (ie a larger number of indications).
    Last edited by Eagle0: Today, 16:15
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.